Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.58 | -16.22 |
PEG Ratio (TTM) | -0.05 | -1.41 |
P/S Ratio (TTM) | N/A | 48.82 |
P/B Ratio (TTM) | 0.72 | 21.13 |
P/FCF Ratio (TTM) | -2.39 | 9.38 |
Price to 5YR AVG Earnings Ratio | -0.90 | -0.21 |
Price to 5YR AVG FCF Ratio | -4.94 | -7.10 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -27.54% | -3.10% |
ROE (TTM) | -42.30% | 24.21% |
Net Profit Margin (TTM) | N/A | -1,069.78% |
ROIC 5YR AVG | -180.04% | 16.50% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 8.62% | -389.24% | -212.87% |
Revenue | N/A | -33.33% | -20.00% |
Net Income | -22.75% | -1,170.98% | -712.81% |
Cash Flow | -35.26% | -457,930.23% | -274,796.14% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 41.70 | 5.75 |
Quick Ratio (TTM) | 41.70 | 5.47 |
D/E Ratio (TTM) | 0.00 | -15.13 |
Interest Coverage (TTM) | N/A | 3.59 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | 17.60 | 13.47 |
LTL to 5YR AVG FCF | N/A | 0.20 |
Shares Outstanding Growth 5YR AVG | 145.32% | 118.86% |